Canada: Life Sciences, Biotechnology & Nanotechnology

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

BCF Acts As Counsel To Celystra Pharma As Part Of An Equity Investment

BCF acted on behalf of Celystra Pharma Inc., a Québec-based biopharmaceutical company managed by Paul Lévesque, John Leasure, and Philippe Dubuc, as part of an equity investment...

Canada Healthcare

BB

BCF Business Law

Ontario Superior Court Limits Damages Claims In Certifying Personal Injury Medical Device Class Action

An Ontario court has held that Ontario’s more restrictive certification regime may require narrowing class members’ damages claims.

Canada Litigation

BJ

Bennett Jones LLP

Northern Advantage: Canada's Federal Court As A Venue For Pharmaceutical Patent Litigation

In the complex and high-stakes world of pharmaceutical patent litigation, selecting the right venue can significantly influence the outcome of a case. For companies marketing or seeking to market pharmaceuticals in Canada...

BJ

Bennett Jones LLP

Deference Prevails: A Public Drug Funding Decision In Québec Is Upheld On Reasonableness Review

In Avir Pharma Inc. c. Minister of Health and Social Services1, the Québec Superior Court dismissed an application for judicial review challenging the Minister’s refusal to include Jorveza—a drug used to treat...

Canada Healthcare

TL

Torys LLP

Class Action Pursued Over Infection Risks Linked To Endoscope Devices

Canada Consumer

SL

Siskinds LLP

Tout ce qu'il faut savoir sur les lignes directrices mises à jour et les exemples 2026 de l'OPIC concernant l'objet brevetable

SB

Smart & Biggar

Canada Announces New Pharmaceutical And Life Sciences Sector Task Force

Canada Healthcare

SB

Smart & Biggar

PMPRB Consults On Proposed Practice Directions For PMPRB Hearings

SB

Smart & Biggar

Le CEPMB lance une consultation concernant le projet de directives relatives à la pratique pour ses audiences

Canada Technology

SB

Smart & Biggar

Changing Life Sciences' Patent Landscape: It's Time To Talk About Efficient Licensing

GW

Gowling WLG

L'intelligence artificielle prescrira-t-elle bientôt des médicaments au Canada? Les leçons du programme novateur de l'Utah

Canada Healthcare

FF

Fasken (French)

Updated Guidance From CIPO On Patentable Subject-Matter

ML

McMillan LLP

Could Artificial Intelligence Soon Prescribe Drugs In Canada? Lessons From Utah's Landmark Program

Canada Healthcare

F

Fasken

Torys On Defence: The Role Of Life Sciences In Canada's Defence Capabilities

Canada Healthcare

TL

Torys LLP

How To Meet The Very High Bar For Establishing And Maintaining Canadian-Controlled Private Corporation (CCPC) Status, Plus Corporate And Tax Implications Of Share Transfer

RS

Rotfleisch & Samulovitch P.C.

Les Excuses En Cas De Diffamation : Une Solution Plus Symbolique Que Juridique?

Canada Litigation

BB

BCF Business Law

Closing The Loophole On Indirect Trust Transfers And The 21-Year Deemed Disposition Rule: New Measure In Budget 2025

RS

Rotfleisch & Samulovitch P.C.

2026 Update On Trends In Indigenous Equity Investments In Canada

Canada Government

F

Fasken

New Principles For AI Use In Ontario

Canada Technology

MT

Miller Thomson LLP

PMPRB Launches Consultation On Proposed Practice Directions For Hearings

The Patented Medicine Price Review Board (PMPRB) has opened a public consultation on proposed Practice Directions governing PMPRB hearings.

Canada Healthcare

MT

McCarthy Tétrault LLP

Federal Court Denies Class Action Certification In Generic Drug Price Fixing Case

The Federal Court has dismissed a request to certify a proposed class proceeding against a large number of generic...

Canada Healthcare

SB

Smart & Biggar

La Cour fédérale rejette une requête en autorisation de recours collectif relative à la fixation des prix de médicaments génériques

La Cour fédérale a rejeté une requête pour obtenir l'autorisation d'exercer un recours collectif contre un grand nombre de fabricants de médicaments génériques nommés comme défenderesses ...

Canada Healthcare

SB

Smart & Biggar

Update On Proposed Ministerial Reliance Order

As we reported last month, the Minister of Health launched a consultation on a proposed Ministerial Reliance Order that would permit Health Canada to complete the examination of certain parts...

Canada Healthcare

SB

Smart & Biggar

Mise à jour sur la proposition d'arrêté ministériel relatif à la confiance

Canada Healthcare

SB

Smart & Biggar

L'Agence des médicaments du Canada annonce une consultation sur le processus d'examen simplifié et de nouvelles procédures en ce qui concerne les reconsidérations et les nouvelles demandes d'examen

Canada Healthcare

SB

Smart & Biggar

Canada's Drug Agency Announces Consultation On Streamlined Review Process And New Reconsideration/resubmission Procedures

Canada Healthcare

SB

Smart & Biggar

New PMPRB Chairperson And PMPRB Releases January 2026 NEWSletter

Canada Healthcare

SB

Smart & Biggar

Nouvelle présidente au CEPMB et publication de l'édition de janvier 2026 de la Nouvelle du CEPMB

SB

Smart & Biggar

U.S. Supreme Court Strikes Down Key Trump Tariffs, But New Measures May Follow

Canada International

GW

Gowling WLG

Healthcare Supply Chains: Managing Modern Slavery Risks In Hospital Procurement

Canada Healthcare

BL

Borden Ladner Gervais LLP

Une proposition d'arrêté ministériel relatif à la confiance pourrait permettre à Santé Canada d'avoir recours à des décisions prises par des autorités réglementaires étrangères reconnues

Canada Healthcare

SB

Smart & Biggar

Les 10 articles incontournables de la Mise à jour en PI Rx en 2025

Canada Healthcare

SB

Smart & Biggar

Top Ten Rx IP Update Reads Of 2025

SB

Smart & Biggar

Healthcare Supply Chains: Managing Modern Slavery Risks In Hospital Procurement

Healthcare organizations should be aware of growing scrutiny over supply chain practices, including with respect to risks of forced and child labour and modern slavery.

Canada Healthcare

BL

Borden Ladner Gervais LLP

Une proposition d'arrêté ministériel relatif à la confiance pourrait permettre à Santé Canada d'avoir recours à des décisions prises par des autorités réglementaires étrangères reconnues

Le 19 décembre 2025, la ministre de la Santé a annoncé le lancement de consultations sur deux initiatives réglementaires...

Canada Healthcare

SB

Smart & Biggar

Les 10 articles incontournables de la Mise à jour en PI Rx en 2025

Voici les articles les plus lus de la rubrique Mise à jour en PI Rx en 2025...

Canada Healthcare

SB

Smart & Biggar

Top Ten Rx IP Update Reads Of 2025

Below are Rx IP Update's most-read articles of 2025...

SB

Smart & Biggar

Top Ten Rx IP Update Reads Of 2025

SB

Smart & Biggar

Une proposition de modernisation du cadre des essais cliniques pour favoriser l'accès à de nouvelles thérapies innovantes au Canada

Le 20 décembre 2025, Santé Canada a lancé une consultation sur la modernisation du cadre des essais cliniques visant les médicaments destinés à l'usage des humains...

Canada Healthcare

SB

Smart & Biggar

Cancer-linked Drug And Product Lawsuits: Legal Pathways For Affected Patients

Patients who have been diagnosed with tumours or cancers after using pharmaceutical or health products may be able to pursue legal claims against manufacturers when credible scientific...

Canada Healthcare

SL

Siskinds LLP

Naming Natural Health Products: Branding In A Grey Zone

Over the course of our previous bulletins, we have examined branding considerations for prescription drugs, over-the-counter drugs, and medical devices.

Canada Healthcare

ML

McMillan LLP

Proposed New Requirements For Lithium-Ion Batteries In Consumer Products

Health Canada has published a Notice of Intent regarding proposed regulations for lithium-ion batteries and consumer products containing lithium-ion batteries (under the Canada Consumer Product Safety Act ("CCPSA")).

Canada Consumer

GR

Gardiner Roberts LLP

How Is AI Transforming The Life Sciences Industry?

Canada Technology

TL

Torys LLP

What You Should Know About The Freestyle Libre 3 Recall

Worldwide Litigation

GP

Gluckstein Lawyers

VC Investment In Canada For Life Sciences Companies

Canada Healthcare

MT

McCarthy Tétrault LLP

Mise à jour sur le CEPMB : Entrée en vigueur des Lignes directrices pour le personnel du CEPMB le 1er janvier 2026 et Rapport annuel 2024

Canada Healthcare

SB

Smart & Biggar

PMPRB Update: Guidelines For PMPRB Staff Come Into Effect January 1, 2026; 2024 Annual Report

Canada Healthcare

SB

Smart & Biggar

Medical Devices Updates: Phase II Consultation On Medical Devices Regulations Amendments, Medical Device Licences Guidance And IMDRF Table Of Contents Guidance

Canada Healthcare

SB

Smart & Biggar

Mise à jour sur les instruments médicaux : Phase II de la consultation sur les modifications au Règlement sur les instruments médicaux, et lignes directrices sur l'homologation d'instruments médicaux et sur la table des matières de l'IMDRF

Canada Healthcare

SB

Smart & Biggar

Santé Canada et la Food and Drug Administration des États-Unis conviennent de mettre en place un programme de partage d'informations pour l'examen des médicaments génériques

Canada Healthcare

SB

Smart & Biggar

L'Agence des médicaments du Canada publie une nouvelle ressource et des données sur le processus d'autorisation et de remboursement des médicaments

Canada Healthcare

SB

Smart & Biggar

Health Canada And U.S. FDA Agree To Establish Information Sharing Program For Generic Drug Submission Reviews

Canada Healthcare

SB

Smart & Biggar

Health Canada Proposes Amendments To MDEL Holders And Applicants

Worldwide Healthcare

BJ

Bennett Jones LLP

Consultation sur les modifications proposées aux exigences relatives aux licences d'établissement d'instruments médicaux

Canada Healthcare

BC

Blake, Cassels & Graydon LLP

Practical Tips On Patent Term Adjustment In Canada

BL

Borden Ladner Gervais LLP

L'APP lance une voie révisée pour les négociations non complexes concernant le prix de médicaments

Canada Healthcare

SB

Smart & Biggar

December 2025 Rosen Sunshine Newsletter

Canada Healthcare

RS

Rosen Sunshine LLP

See more

Latest Videos

See more

Lois canadiennes, américaines, britanniques et européennes entourant l'Internet des objets (Video)

BL

Borden Ladner Gervais LLP

The Legal Steps To Startups: Health & Life Science (Video)

PM

Parlee McLaws

Navigating Life Sciences Procurement And Responding To RFPs (Video)

TL

Torys LLP

Le Secteur De La Santé Au Canada Après La COVID-19 : Perspectives Juridiques, Médicales Et Commerciales (vidéos)

SE

Stikeman Elliott LLP

Lifecycle Of A Smart Idea: Patent Strategy - Optimising Life Sciences Patents (Video)

GW

Gowling WLG

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More